Journal Watch · Journal of Medicinal Chemistry · 2026

A 16 × 8 Focused Compound Library Comprising All Configurational Isomers of the Archetypal Iminosugar, 1-Deoxynojirimycin.

We believe that our comprehensive library, as reported here, could prove valuable in drug discovery endeavors targeting cancer, infectious diseases, and inherited glycosphingolipidoses.

van den Berg RJBHN, van den Nieuwendijk AMCH, Liu B et al.Journal of Medicinal Chemistry3 min readPharma relevance 50/100

DOI: 10.1021/acs.jmedchem.6c01210PMID: 42679158Study type: research study

TL;DR

We believe that our comprehensive library, as reported here, could prove valuable in drug discovery endeavors targeting cancer, infectious diseases, and inherited glycosphingolipidoses.

Key findings

  • In contrast to our expectations, we found that the same holds true for the L-alt isomer.
  • We believe that our comprehensive library, as reported here, could prove valuable in drug discovery endeavors targeting cancer, infectious diseases, and inherited glycosphingolipidoses.

What they did

This paper describes the assembly of such a library with each configurational isomer present in eight N-substituted forms. Screening of this library against the three glucosylceramide processing enzymes, glucosylceramide synthase (GCS), lysosomal glucosylceramidase (GBA1), and nonlysosomal glucosylceramidase (GBA2), confirms earlier data that appropriately substituted D-Glc, D-Gal, and L-Ido deoxynojirimycins are most effective in dually inhibiting GCS and GBA2.

Full abstract (original)

Background: Deoxynojirimycin is the archetypal iminosugar, from which many structural and configurational isosteres have been derived and studied in past decades. In total, 16 configurational isomers of deoxynojirimycin exist, but these have not yet been collected in a single library.

What they did: This paper describes the assembly of such a library with each configurational isomer present in eight N-substituted forms. Screening of this library against the three glucosylceramide processing enzymes, glucosylceramide synthase (GCS), lysosomal glucosylceramidase (GBA1), and nonlysosomal glucosylceramidase (GBA2), confirms earlier data that appropriately substituted D-Glc, D-Gal, and L-Ido deoxynojirimycins are most effective in dually inhibiting GCS and GBA2.

Results & conclusions: In contrast to our expectations, we found that the same holds true for the L-alt isomer. We believe that our comprehensive library, as reported here, could prove valuable in drug discovery endeavors targeting cancer, infectious diseases, and inherited glycosphingolipidoses.

Abstract © the authors / Journal of Medicinal Chemistry (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1021/acs.jmedchem.6c01210 · PubMed 42679158.

Why it matters for pharma & biotech

  • Relevant to Pharmacology & Drug Discovery teams tracking Journal of Medicinal Chemistry for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Journal of Medicinal Chemistry study find?

We believe that our comprehensive library, as reported here, could prove valuable in drug discovery endeavors targeting cancer, infectious diseases, and inherited glycosphingolipidoses.

What type of study is this?

It is a research study, published in Journal of Medicinal Chemistry in 2026. This paper describes the assembly of such a library with each configurational isomer present in eight N-substituted forms.

Where can I read the original paper?

The original is at the publisher via DOI 10.1021/acs.jmedchem.6c01210. PubMed ID: 42679158. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: van den Berg RJBHN, van den Nieuwendijk AMCH, Liu B et al.. A 16 × 8 Focused Compound Library Comprising All Configurational Isomers of the Archetypal Iminosugar, 1-Deoxynojirimycin.. Journal of Medicinal Chemistry (2026). DOI: 10.1021/acs.jmedchem.6c01210.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/a-16-8-focused-compound-library-comprising-all-configurational-isomers-o-c01210/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides